Market Overview
The Lung Pulmonary Airway Disease Treatment Market is experiencing steady expansion, projected to rise from USD 2,021 million in 2024 to an estimated USD 3,031.74 million by 2032, at a compound annual growth rate (CAGR) of 5.2% during the forecast period. This growth trajectory reflects the increasing prevalence of chronic pulmonary airway diseases such as chronic obstructive pulmonary disease (COPD), asthma, and bronchitis worldwide. A growing aging population, combined with heig